MENU

Eureka projects

Medicines with strongly enhanced in vivo stability, optimal receptor interaction, and early indication of clinical success.

Development of a fully human bispecific therapeutic antibody for T cell mediated eradication of Acute Myeloid Leukemia

To develop a certified diagnostic test for monitoring disease activity in patients with inflammatory bowel disease

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.